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Abstract 
 
The scale of impact that COVID-19 has on society and the economy globally, provides a 
strong incentive to thoroughly analyse the efficiency of healthcare systems in dealing with 
the current pandemic and learn some lessons that will help prepare healthcare systems to 
be better prepared for future pandemics. We use Data Envelopment Analysis (DEA) and 
data compiled from Worldometers (2020), and The World Bank (2020a, 2020b & 2020c) to 
analyse how efficient the use of resources were to stabilise the rate of infections and 
minimise death rates in 36 countries that represented 90% of global infections as at 11 
November 2020. This is the first paper to model technical efficiency of countries in managing 
the COVID-19 pandemic by modelling death rates and infection rates as undesirable outputs 
using the approach developed by You & Yan (2011). We find that the average efficiency of 
global healthcare systems in managing the pandemic is very low, with only six efficient 
systems out of a total of 36 under the variable returns to scale assumption. This finding 
suggests that holding constant the size of their healthcare systems (because countries 
cannot alter the size of a healthcare system in the short run), most of the sample countries 
showed low levels of efficiency during this time of managing the pandemic; instead, it is 
suspected that most countries literally “threw” resources at fighting the pandemic, thereby 
probably raising inefficiency through wasted resource use.  
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1. Introduction 
Since it first emerged in China in late December 2019, the new coronavirus (Covid-19) has 
spread to nearly every country of the world (Newey and Gulland, 2020). Within seven 
months, it had spread to 215 countries and regions. On 08 August 2020, Worldometers 
(2020) reported that more than 19.6 million people were known to be infected and more than 
700,000 deaths had been recorded since the outbreak. Countries have adopted pandemic 
spread mitigating interventions referred to as non-pharmaceutical interventions (NPIs), such 
as social distancing, testing and contact-tracing, case isolation and public hygiene at an 
unprecedented scale (Correia et al. 2020).  
 
Even with these drastic NPI interventions, the spread of the pandemic seems to have 
exploded, especially with surges in contagion experienced in countries like Italy, France the 
UK and the USA. This put immense strain on availability of especially ICU facilities and 
available doctors and nurses, and the efficiency of healthcare systems are put under the 
spotlight. What we learn from recent experiences in the fight against this deadly disease 
from countries like South Korea, is that accessibility to healthcare services can significantly 
reduce the number of deaths (Tang et al., 2020). 
 
It is for this reason and the scale of impact that COVID-19 has on society and the economy 
globally, that the efficiency of healthcare systems need to be thoroughly examined in order 
to inform appropriate policy responses that will help prepare health systems globally to be 
better equipped when dealing with the next pandemic.  We address this issue applying Data 
Envelopment Analysis (DEA) and extensive data compiled from Worldometers (2020), and 
The World Bank (2020a, 2020b & 2020c). Specifically, we analyse the efficient use of 
available resources to stabilise the rate of infections and minimise the case-fatality rates in 
selected 36 countries comprising 90% of global infections as at 11 November 2020. Our 
initial sample was overtaken by events. These countries also account for 67% of recoveries 
and 92% of global deaths (Worldometer 2020). Our contribution to the literature is twofold: 
First, this paper is the first that models technical efficiency of countries in dealing with the 
COVID-19 pandemic by modelling death rates and infection rates as undesirable outputs 
and, second, modelling comparative scenarios to test the accuracy of our model. 
 
2. Literature review 
DEA has been applied extensively to compare efficiency of health care facilities within 
countries and between countries, and we briefly deal with some of that literature here. We do 
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not deal with the literature on country studies because our paper compares efficiency 
between countries. For literature on efficiency studies among different healthcare facilities 
within a country, see for example Ngobeni, et al. (2020); Campanella et al. (2017); Alhassan 
et al. (2015); Jarjue et al. (2015); Chowdhury et al. (2010); Gannon (2005); Marschall and 
Flessa (2009); Akazili et al. (2008); Masiye (2007); Zere et al. (2006); Kirigia et al. (2001); 
and Kirigia et al. (2000).   
 
Although healthcare is one of the most popular areas of application for DEA (Liu et al. 2013), 
DEA studies on healthcare systems worldwide are still limited. For example, Bhat  (2005)  
used  DEA  to measure the impact of financial  and  institutional  arrangements  on  national  
healthcare system  efficiency  in  24  OECD  countries. Lo Storto and Goncharuk (2017) 
applied DEA to measure the technical efficiency of 32 European (EU) countries. Afonso and 
St Aubyn (2006) used a two-stage DEA  to estimate a  semi-parametric  model  of  the  
healthcare  systems  in  30 OECD  countries the years 1995  and  2003. De Cos and Moral-
Benito (2014) estimated alternative measurements of efficiency using DEA and SFA 
between 1997 and 2009 to ascertain the most important determinants of healthcare 
efficiency across 29 OECD countries. Hadad et al. (2013) compared healthcare system 
efficiency of 31 OECD countries with two model specifications, one including inputs under 
management control and the other inputs beyond management control. Kim and Kang 
(2014), used a bootstrap DEA to estimate efficiency of healthcare systems in a sample of 
170 countries. 
 
Although the choice of inputs is similar in these studies, outputs selection depends mostly on 
the purpose of the research. For example, Gonzalez et al. (2010), in a cross-sectional study 
measured the technical and value efficiency of health systems in 165 countries. They used 
expenditure on health and education as inputs and data on healthy life expectancy and 
disability adjusted life years as health outcomes. Examining the efficiency in healthcare 
services delivery to the population, Bhat (2005) uses the number of populations aged 0-19 
years, 20-64, and 65 or older as outputs. Santos et al. (2012) examine the efficiency of 
countries in preventing the mother-to-child HIV transmission and used the number of 
pregnant women tested for HIV and the number of HIV pregnant women receiving 
antiretroviral drugs as outputs.  
 
DEA studies for new settings such as the recent COVID-19 outbreak may however need to 
introduce new outputs. Shirouyehzad et al. (2020) uses DEA to analyse the efficiency of 
contagion of COVID19 and focus on the number of deaths and recoveries as outcomes. 
Breitenbach, et al, (2020), analyse the 31 most infected countries during the first 100 days 
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since the outbreak of the COVID-19 coronavirus for the efficiency in containing the spread of 
the virus and focus on flattening the curve as the main output. Empirical work pivots mostly 
on healthcare system performance based on technical efficiency calculated as a ratio of 
some quality of life variable as an output and physical health resources or expenditure on 
health as inputs. The inputs most used were expenditure, doctors and nurses while the 
outputs were discharge or recovery, prevalence and mortality rates. In this paper we use 
tests, doctors and nurses as physical inputs and health spending as financial input in 
managing the COVID-19 pandemic. As outputs we use case-fatality (deaths) and infection 
prevalence rates. 
 
3.1. Methodology 
In this paper, we use the variable returns to scale (VRS) approach reported by Gavurova et 
al. (2017) and developed in 1984 by Banker, Charnes and Cooper (BCC model) to allow for 
consideration of scale efficiency analysis. Envelopment in DEA refers to the ability of the 
efficiency production frontier to tightly enclose the production technology (input and output 
variables). According to Cooper et al. (2007) and McWilliams et al. (2005), DEA was 
developed in a microeconomic setting and applied to firms to measure the efficiency of 
converting inputs into outputs. In the analysis of public institutions, firms are replaced by the 
more encompassing decision-making units (DMU). DEA is therefore an appropriate method 
of computing the efficiency of institutions employing multivariate production technologies. 
Aristovnik (2012) and Martić et al. (2009), distinguish between input-minimisation and 
output-maximisation DEA models. The former determines the quantity of inputs that could be 
curtailed without reducing the prevailing level of outputs and the latter expands the outputs 
of DMUs to reach the production possibility frontier while holding the inputs constant. 
However, the selection of each orientation is study-specific. In this paper, we select the input 
minimisation orientation. 
According to Taylor and Harris (2004), DEA is a comparative efficiency measurement tool 
that evaluates the efficiency of homogeneous DMUs operating in similar environmental 
conditions, for example, DMUs dealing with COVID-19 and where the relationship between 
inputs and outputs is unknown. We follow Joumard et al. (2008) to treat the whole healthcare 
system in a given country as a DMU in order to analyse the healthcare system at the 
aggregate level. We also adopt the VRS methodology in this study because of heterogeneity 
among the DMUs in terms of factors like country size and income. In terms of the DEA 
methodology, the current study uses the BCC model with the ratio of DMUs being 4 times 
the combined number of inputs and outputs to ensure the stability of the efficiency results.  
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3.2. Modelling undesirable outputs 
DEA models have found increasing use in efficiency analysis applications where at least one 
output in the production process is an undesirable output, e.g. pollution. There is 
considerable research published on the undesirable aspects of production outputs. However, 
You and Yan (2011) have found that the economic implications and the suitability of DEA 
models incorporating the undesirable outputs should be carefully considered as the results 
may either under- or overstate efficiency if modelled incorrectly.  
The first way that undesirable outputs are dealt with in the traditional DEA model, is to ignore 
the undesirable output (Nakashima et al, 2006; Hua and Bian, 2007; Lu and Lo, 2007a, b). It 
is not however, appropriate to ignore the reality of e.g. pollution during production since 
undesirable outputs and desirable outputs are generated simultaneously in the production 
process. Dyckhoff and Allen (2001) dealt with undesirable outputs by modelling them as 
inputs. However, treating undesirable outputs as inputs fails to reflect the true production 
process. There is a specific production technology that links inputs to outputs, and taking an 
undesirable output as an input in the production process leads to misspecification and 
misinterpretation, for example, when modelling the pollution as an input using an output-
oriented measure, ecological inefficiencies remain undetected. Golany and Roll (1989) 
suggested a data transformation approach where an undesirable output is converted into a 
‘normal’ output by a monotonic decreasing function. The undesirable outputs (carbon and 
nitrogen emissions) are treated as normal outputs by taking their reciprocals. Although the 
pollutant is treated as output, the scale and intervals of the original data get lost and problem 
with zero values is that it does not have a reciprocal value. The Linear monotonic decreasing 
transformation was suggested by Seiford and Zhu (2002). A sufficiently large positive scalar 
βi is added to the reciprocal additive transformation of the undesirable output i so that the 
final values are positive for each DMUk. This model is criticised for its invariance to data 
transformation within the DEA model (Lu and Lo, 2007a, b).  Fӓre et al., (1989) treats 
undesirable factors in a non-linear DEA model based on the weak disposability of 
undesirable outputs (Zhou et al, 2007). Weak disposability assumes that to reduce 
undesirable outputs it is costly because simultaneously, it increases the inputs or decreases 
desirable outputs (Yang et al, 2008). It tends to increase the desirable output and 
undesirable output at the concurrently. Regardless of the form of transformation, as long as 
the final value of undesirable output included in the DEA calculation remains positive, it 
increases the efficiency of the DMU. An undesirable output should bring either a negative or 
positive impact to the performance of DMU; therefore it is not appropriate for the undesirable 
output to solely favour the efficiency score. 
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After comparing the performance of the models discussed above, You and Yan (2011) 
developed the ratio model, which outperformed all five of these models developed for 
dealing with undesirable outputs. We therefore opted to adopt the ratio model for the current 
paper. The ratio model is different from the previous approaches in that the undesirable 
output is aggregated in a ratio form with the desirable output. 
From the conventional BCC DEA model and assuming that there are R DMUr (r = l, 2, . . . , R), 
that convert m inputs to n outputs, DMUk is one of the R DMUs being evaluated. It is further 
assumed that DMUk consumes m inputs 𝑋𝑡𝑘 (i = 1, 2, . . . , m) to produce n outputs 𝑌𝑗𝑘   (j = 1, 2, 
. . . , n) and all these outputs are assumed to be desirable. The measure of efficiency of DMUk 
is then obtained by: 
min θ subject to 
∑ 𝜆𝑟𝑅𝑟=1 𝑋𝑖𝑟 − 𝜃𝑋𝑖𝑘 + 𝑠𝑖− = 0                                           𝑖 =  1, 2 , . . . , 𝑚 ∑ 𝜆𝑟 𝑅𝑟=1 𝑌𝑗𝑟 − 𝑠𝑗+ =  𝑌𝑗𝑘                                                    𝑗 =  1, 2, . . . , 𝑛 ∑ 𝜆𝑟𝑅𝑟=1  = 1 𝜆𝑟, 𝑠𝑖−, 𝑠𝑗+  ≥ 0                                                   𝑟 = 1, … , 𝑅                                                     (3) 
where DMUr = the rth DMU, r = 1,2, . . . , R; DMUk = the kth DMU being evaluated; 𝑋𝑖𝑟,  𝑌𝑗𝑟= 
the inputs and outputs of every DMUr; i = 1, 2, . . . , m, j = 1,2, . . . , n; θ = the efficiency of 
DMUk;   λr = the dual variable corresponding to the other inequality constraint of the primal; 𝑠𝑖−,    𝑠𝑗+  = the slack variables that turn the inequality constraint into an equal form; 𝜆𝑟,∗  𝑠𝑖−∗, 𝑠𝑗+∗ = the optimal solutions when the relative efficiency of DMUk is 𝜃∗ = 1 and 𝑠𝑖−∗ =  𝑠𝑗+∗ = 0. 
In the ratio model, the undesirable output and desirable output are defined as 𝑂𝑞 − (𝑞 =1. 2, … , 𝑛1) and 𝑂𝑝+ (𝑝 = 1, 2, … , 𝑛2), respectively (𝑛1 +  𝑛2 = 𝑛). For DMUk, the undesirable 
outputs 𝑂𝑞−(𝑞 = 1, 2, … , 𝑛1) are treated as a new variable 𝜓𝑘, which is called the penalty 
parameter and is written as: 𝜓𝑘 =  𝜌1𝑂1𝑘− + ⋯ + 𝜌𝑛1𝑂𝑛1𝑘−                                                                                             (4) 
where 𝜓𝑘 = penalty parameter for DMUk; 𝜌𝑞 = the penalty for individual undesirable output 
(𝑞 = 1, 2, … , 𝑛1); 𝑂𝑞 − = the undesirable output (𝑞 = 1, 2, … , 𝑛1). Since 𝜌𝑞 is the penalty 
charged for producing the outputs, the 𝜓𝑘 obtained from problem (4) gives a measure of the 
total monetary value of undesirable outputs. From the definition of 𝜓𝑘 ,  the greater the 
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amount of undesirable output, the greater is the value of the penalty parameter. Further, the 
respective value of 𝜌𝑞 is associated with the individual undesirable output, therefore 𝜌𝑞 has 
the same value for every DMU. With this model, desirable and undesirable outputs can 
relate to one another, regardless of disagreement in the units. With the new approach of 
treating the undesirable outputs in (4), the desirable output p (𝑝 = 1, 2, … , 𝑛2) of DMUk in the 
ration model is modified as : 
𝑌𝜌′ =  1𝜓𝑘 𝑂𝑝+,                                      (𝑝 = 1, 2, … , 𝑛2)                                                    (5) 
where 𝑂𝑝+= the desirable output (𝑝 = 1, 2, … , 𝑛2); 𝑌𝜌′ = the modified output (𝑝 = 1, 2, … , 𝑛2). 
The ratio model computes desirable and undesirable outputs as fractions, where undesirable 
output 𝑂𝑞− is the denominator and desirable output 𝑂𝑝+ the numerator. Here the value of the 
output is interpreted as a ratio of desirable to undesirable output. Using ratios provides a 
simple and easy way to expose the impact of undesirable outputs in a DEA. The ratio form of 
the DEA model can satisfy the restrictions of the conventional DEA, which the output 
variable states must be a positive value. Moreover, the ratio form provides a more distinct 
way for the desirable and desirable output to describe the presence of an undesirable output 
on DMU efficiency. 
In order to check the stability of our model results, we ran three different model 
specifications and compared the results. In Model I, we use the number of tests and number 
of doctors and nurses as physical inputs, health expenditure as financial input and as output 
the ratio of recoveries to infection rates (ratio of desirable to undesirable output). In Model II, 
we use the number of tests and number of doctors and nurses as physical inputs, health 
expenditure as financial input and as output the ratio of recoveries to death rates (ratio of 
desirable to undesirable output) and in Model III, we use the number of tests and number of 
doctors and nurses as physical inputs, health expenditure as financial input and as output 
the number of recoveries. In Model III we therefore ignore the undesirable outputs 
(Nakashima et al, 2006; Hua and Bian, 2007; Lu and Lo, 2007a, b). Although it is not good 
to ignore the undesirable outputs of the rate of new infections and death rates, we do this in 
order to compare the difference that the inclusion of the undesirable outputs in our model 
has on the efficiency scores.  
           3.3. Data 
Our data are gathered from different sources. The COVID-19 related data (i.e. Infected 
Cases, Recovered Cases and Deaths and number of tests) are extracted from extensive 
data compiled from Worldometers (2020). Aggregated data on Doctors and Nurses per     
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100 000 of the population, and healthcare expenditure were obtained from World 
Development Indicators (WDI) provided by The World Bank (2020a, 2020b & 2020c).  
Table 1: Descriptive statistics and variables used in the model 
 
Some descriptive statistics of those variables are reported in Table I indicate that our sample 
countries have, on average, a resource of nearly seven doctors and nurses per 1000 of the 
population, a budget of about 17% of GDP and 200 850 tests per 1 million of the population 
for its healthcare system. The number of infected cases and deaths from COVID-19 over the 
study period averaged more than 1 295 120 and 32 821, respectively; and the mean number 
of people recovering from the infection around 974 487 persons. Assuming that the whole 
healthcare system is mobilised to fight the COVID-19 outbreak, how efficient was the 
mobilisation of resources? This issue is analysed with our DEA model and the results 
reported in the next section.  
4. Results 
The results of the three model variants is graphically illustrated in Figure 1 and the results in 
Table 1 (Annexure). As intimated earlier in this paper, it is important to consider the VRS 
technical efficiency scores motivated by the differences in the size of healthcare systems 
globally, particularly between large developed economies and small less-developed 
economies. The VRSTE are almost identical across the three model variants. This points to 
two things: First, the inclusion of undesirable outputs in our model (variants I and II), does 
not have any material impact on the mean technical efficiency of country healthcare 
systems, and second, it points to the stability of our results across the three model variants. 
For the sake of simplicity, we therefore discuss only the results reflected in Model I, where 
our physical inputs were the number of tests/million of the population and number of doctors 
and nurses per 100 000 of the population; our financial input healthcare expenditure as a 
percentage of GDP and our output recoveries/infections. Under the CRS assumption, there 
were only two efficient healthcare systems in dealing with COVID-19, viz. Bangladesh and 
Variables Unit Mean Standard Deviation Minimum Maximum
Physical Inputs
No. of Tests per million of the population 200849.78 159220.81 15033.00 541193.00
No. of Doctors & Nurses per 1000 of the population 7.00 5.00 1.00 22.00
Financial Input
Health expenditure % of GDP 8.00 3.00 3.00 17.00
Desirable output
Recovery Rate No. of people 974486.67 1844065.41 30504.00 8023412.00
Undesirable outputs
Death Rates No. of People 32820.67 50619.93 1174.00 245989.00
Infection Rates No. of People 1295119.31 2265355.91 175711.00 10575373.00
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Pakistan. When the VRS assumption is considered, the figure rises as expected, in this case 
to six, with the addition of Brazil, Chile, Indonesia and Morocco.   
Figure 1: CRS and VRS efficiency scores of global healthcare systems 
 
 
Note: CRSTE represents technical efficiency under constant returns to scale assumption; 
VRSTE represents technical efficiency under variable returns to scale assumption; and SE 
represents scale efficiency. 
Source: Authors’ graph from results 
 
These differences, regarding the full sample of 36 countries, are statistically significant under 
a Mann-Whitney-Wilcoxon’s test (Z = 5.271, p = 0.001). It indicates the role of scale 
efficiency (SE) in our analysis because it is the objective of the global healthcare systems to 
achieve the optimal technical combination of the inputs to produce the outputs, but their 
scales (sizes) are not optimal yet. Although 21 of the 36 countries in our sample are 
CRSTE VRSTE SE CRSTE VRSTE SE CRSTE VRSTE SE
Mean 0.43 0.53 0.76 0.3 0.52 0.51 0.14 0.53 0.22
Standard deviation 0.27 0.256 0.233 0.266 0.244 0.27 0.235 0.256 0.258
Maximum 1 1 1 1 1 1 1 1 1
Minimum 0.03 0.18 0.11 0.01 0.18 0.03 0 0.27 0.01
No. of Efficient 2 6 10 2 5 2 2 6 2
No. of Inefficient 34 30 26 34 31 34 34 30 34
Model I: Output - recoveries/infectionsModel II: Output - recoveries/deaths Model III: Output - Recoveries
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operating under increasing returns to scale, the technical combination of inputs to produce 
the existing output is still not optimal. Six of the 36 countries operate under decreasing 
returns to scale (see the Appendix), suggesting that they can double their inputs without 
doubling their output. These countries could therefore rationalise their healthcare 
resources/inputs by downsizing (using resources/inputs more efficiently) and, thereby, 
improving the technical efficiency, while the outputs can still stay the same. At first glance it 
is often difficult to envisage a country with a large undesirable output to be technically 
efficient. Brazil for example, has a very high number of infections and deaths, yet our DEA 
results show that Brazil is technically efficient and lies on the efficiency frontier. To gain 
further insight into this number and the associated DEA efficiency scores, it is helpful to 
compare inputs and outputs of a benchmark country like Brazil, relative to that of other 
countries. We have done this in Table 2.   
Table 2: Inputs and outputs relative to benchmark country (Brazil) 
 
Source: Calculated from Table 3 results 
 
For example, in comparison to Brazil, the USA spends 4.25 times more as a percentage of 
GDP on Healthcare, has 3.5 times more doctors and nurses per 100 000 of the population, 
and had 471% more COVID-19 tests performed relative to Brazil; yet it did not succeed to 
contain its undesirable outputs (Infections are 185% higher and deaths 151% higher than 
Brazil) even though it performed well in the area of the good output, recoveries. This result 
clearly explains the relatively low VRS technical efficiency scores of the USA, France, 
Germany and Belgium in Table 2, which could be linked to specific policy responses of 
selected countries. For example, evidence now suggests that the UK failed to fight the 
COVID-19 outbreak by following a ’herd immunity’ approach (Stewart et al., 2020) and the 
USA was very slow to act against COVID-19 (Watts, 2020). 
5. Conclusions 
This paper examined the efficiency of 36 healthcare systems (which represent 90% of cases 
globally) in managing the COVID-19 pandemic, given their resources constraints. We use a 
novel DEA approach, developed by You and Yan (2011), which accounts for both desirable 
Country VRSTE Expenditure (% of GDP) Doctors & Nurses/100 000 No. of Tests Infections Deaths Recoveries
Brazil 1 4 4 102,766              5,701,283        162,842         5,964,344        
USA 0.18 17 14 484,227              10,575,373      245,989         6,603,470        
France 0.27 11 14 279,353              1,829,659        42,207           131,920           
Germany 0.27 11 17 278,886              710,265           11,912           454,800           
Belgium 0.27 11 14 458,403              507,475           13,561           30,504             
USA/Brazil 4.25 3.5 471.19% 185.49% 151.06% 110.72%
France/Brazil 2.75 3.5 271.83% 32.09% 25.92% 2.21%
Germany/Brazil 2.75 4.25 271.38% 12.46% 7.32% 7.63%
Belgium/Brazil 2.75 3.5 446.06% 8.90% 8.33% 0.51%
Comparison with Brazil
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outputs (recovered cases) and undesirable outputs (infections and deaths) and our results 
indicate that the average efficiency of global healthcare systems in managing the COVID-19 
pandemic is very low, with only six efficient systems out of a total of 36 under the variable 
returns to scale assumption. This finding suggests that holding constant the size of their 
healthcare systems (because countries cannot alter the size of a healthcare system in the 
short run), most of the sample countries could not improve their efficiency during this time of 
managing the pandemic; instead, it is suspected that most countries literally “threw” 
resources at fighting the pandemic, thereby probably raising inefficiency through wasted 
resource use.  The study also showed that developed countries could also draw lessons 
from developing countries in the management of pandemics. The latter countries mostly face 
pandemics on a daily basis, therefore, have developed strategies for efficiently managing 
them. 
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Annexure A: Table 3: Analytical variables and efficiency scores 
 
Sources: Authors’ Table based on DEA efficiency calculated results. 
DMU # Country
CRS 
efficiency 
score
VRS 
efficiency 
score Scale
Type 
of 
scale
CRS 
efficiency 
score
VRS 
efficiency 
score Scale
Type 
of 
scale
CRS 
efficienc
y score
VRS 
efficienc
y score Scale
Type 
of 
scal
e
1 USA 0.12 0.18 0.67 IRS 0.07 0.18 0.39 IRS 0.29 0.33 0.89 DRS
2 India 0.33 0.33 1.00 -     0.38 0.39 0.96 DRS 1.00 1.00 1.00 -     
3 Brazil 0.83 1.00 0.83 DRS 0.40 0.75 0.54 IRS 1.00 1.00 1.00 -     
4 Russia 0.47 0.60 0.78 IRS 0.37 0.60 0.62 IRS 0.18 0.64 0.29 IRS
5 France 0.03 0.27 0.11 IRS 0.01 0.27 0.04 IRS 0.01 0.27 0.03 IRS
6 Spain 0.22 0.33 0.67 IRS 0.11 0.33 0.33 IRS 0.07 0.34 0.19 IRS
7 Argentina 0.33 0.33 1.00 -     0.16 0.33 0.48 IRS 0.16 0.36 0.46 IRS
8 UK 0.20 0.30 0.67 IRS 0.07 0.30 0.22 IRS 0.05 0.31 0.17 IRS
9 Columbia 0.43 0.43 1.00 DRS 0.22 0.43 0.50 IRS 0.16 0.45 0.34 IRS
10 Italy 0.15 0.33 0.44 IRS 0.04 0.33 0.13 IRS 0.03 0.33 0.08 IRS
11 Mexico 0.67 0.77 0.87 IRS 0.11 0.77 0.14 IRS 0.40 0.95 0.42 IRS
12 Peru 0.60 0.60 1.00 -     0.21 0.60 0.35 IRS 0.15 0.62 0.24 IRS
13 South Africa 0.50 0.50 1.00 -     0.30 0.50 0.61 IRS 0.13 0.54 0.24 IRS
14 Iran 0.26 0.33 0.78 IRS 0.07 0.33 0.22 IRS 0.09 0.34 0.27 IRS
15 Germany 0.18 0.27 0.67 IRS 0.15 0.27 0.55 IRS 0.03 0.27 0.10 IRS
16 Poland 0.17 0.38 0.45 IRS 0.15 0.38 0.41 IRS 0.03 0.38 0.07 IRS
17 Chile 0.67 1.00 0.67 DRS 0.30 0.60 0.49 IRS 0.09 0.61 0.15 IRS
18 Iraq 0.60 0.60 1.00 -     0.37 0.60 0.62 IRS 0.09 0.60 0.15 IRS
19 Belgium 0.03 0.27 0.11 IRS 0.01 0.27 0.03 IRS 0.00 0.27 0.01 IRS
20 Ukraine 0.24 0.43 0.55 IRS 0.16 0.43 0.36 IRS 0.03 0.43 0.07 IRS
21 Indonesia 0.95 1.00 0.95 IRS 0.44 1.00 0.44 IRS 0.23 1.00 0.23 IRS
22 Czechia 0.29 0.43 0.67 IRS 0.32 0.43 0.75 IRS 0.03 0.43 0.06 IRS
23 Bangladesh 1.00 1.00 1.00 -     1.00 1.00 1.00 -      0.43 1.00 0.43 IRS
24 Netherlands 0.18 0.27 0.67 IRS 0.13 0.27 0.46 IRS 0.02 0.27 0.07 IRS
25 Philippines 0.60 0.60 1.00 -     0.46 0.60 0.77 IRS 0.08 0.60 0.14 IRS
26 Turkey 0.60 0.60 1.00 -     0.27 0.60 0.45 IRS 0.05 0.60 0.09 IRS
27 Saudi Arabia 0.42 0.70 0.60 DRS 0.33 0.40 0.83 IRS 0.04 0.38 0.10 IRS
28 Pakistan 1.00 1.00 1.00 -     0.82 1.00 0.82 IRS 0.16 1.00 0.16 IRS
29 Romania 0.47 0.60 0.78 IRS 0.23 0.60 0.38 IRS 0.03 0.60 0.05 IRS
30 Israel 0.42 0.50 0.83 DRS 0.63 0.65 0.97 IRS 0.03 0.38 0.07 IRS
31 Canada 0.27 0.30 0.89 IRS 0.09 0.30 0.30 IRS 0.02 0.30 0.05 IRS
32 Morocco 0.89 1.00 0.89 IRS 0.88 1.00 0.88 IRS 0.02 1.00 0.02 IRS
33 Switzerland 0.19 0.33 0.56 IRS 0.19 0.33 0.58 IRS 0.01 0.33 0.03 IRS
34 Nepal 0.44 0.50 0.89 IRS 1.00 1.00 1.00 -      0.03 0.50 0.07 IRS
35 Portugal 0.20 0.30 0.67 IRS 0.16 0.30 0.52 IRS 0.01 0.30 0.02 IRS
36 Ecuador 0.52 0.66 0.79 DRS 0.10 0.46 0.21 IRS 0.05 0.46 0.11 IRS
Mean 0.43 0.53 0.76 0.30 0.52 0.51 0.14 0.53 0.22
# of effic. DMUs 2 6 10 2 5 2 2 6 2
Model I Model II Model III
